Effect of Sarcopenia in Stroke Patients

The Catholic University of Korea

Status

Completed

Conditions

Stroke

Sarcopenia

Treatments

Diagnostic Test: DEXA Scan

Study type

Observational

Funder types

Other

Identifiers

NCT05671705

VC22ONDI0185

Details and patient eligibility

About

Primary research purpose:

-Prospective study to screen post stroke patients with sarcopenia and evaluate its effect on recovery

Secondary research purpose:

To determine the degree of sarcopenia and correlation with poor functional prognosis of stroke in the stroke patient group.
To determine the degree of sarcopenia and correlation with dixon MRI of thigh muscle
To evaluate surface EMG (SEMG)-based signals and correlation with sarcopenia
To determine the degree of sarcopenia and correlation with brain morphometric changes

Full description

Patients with first-ever stroke will be enrolled and assessed for sarcopenia. The evaluation parameters will include standard sarcopenia parameters and also SEMG-based signals and imaging studies.

Enrollment

83 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients 65 years of age or older, stroke patients with first onset within 4 weeks

Exclusion criteria

Patients who have not been evaluated for sarcopenia
Patients with neuromuscular diseases other than stroke that may affect gait function
Patients unable to conduct clinical trials according to instructions
Patients with uncontrolled medical/surgical disease
Patients with metal substances in the body such as cardiac pacemakers, cochlear implants, etc.
Patients who have difficulty collecting blood
Patients who are difficult to follow up after 6 months of onset due to moving to another area
Patients who have Parkinson's disease, dementia, or have a history of neuromuscular diseases such as Guillain-Barré syndrome or myasthenia gravis